MedPath

Comparing Different Startegies of Positive Pressure Ventilation in Children

Not Applicable
Recruiting
Conditions
Ventilation Therapy; Complications
Interventions
Other: volume controlled ventilation
Other: pressure controlled ventilation
Other: pressure controlled volume grantanteed ventilation
Registration Number
NCT06612125
Lead Sponsor
Beni-Suef University
Brief Summary

The most basic modes of mechanical ventilation are volume-controlled ventilation (VCV) and pressure-controlled ventilation (PCV). VCV guarantees a target volume of ventilation using a constant flow, but may lead to high peak airway pressure (Ppeak) during the gas insufflation . In PCV mode, on the other hand,

Detailed Description

The laryngeal mask airway (LMA) provides a useful alternative for airway management during general anaesthesia. Inflation of the LMA cuff produces a low-pressure seal around the larynx, enabling positive pressure ventilation (PPV). The use of LMA as an airway management technique is common in the pediatric anesthesia because of its less irritating effect on the airways due to its location in the upper larynx. Now, the use of laryngeal mask instead of tracheal intubation for airway management has been achieved in day surgery, therefore, how to perform a respiratory management with a laryngeal mask is particularly important. In addition, mechanical ventilation is also a commonly used method of airway management in clinical practice. the ventilator will deliver a constant pressure by decelerating the flow. However, the ventilation volume varies according to the patient's respiratory mechanics . Pressure-controlled ventilation-volume guaranteed (PCV-VG) combines the advantages of both VCV and PCV, which delivers a stable ventilation volume using a decelerating flow pattern.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
78
Inclusion Criteria
  1. age between 1 and 5 years.
  2. patient scheduled for laparoscopic inguinal hernia repair.
  3. American Society of Anesthesiologists classification of physical status of I-II.
Exclusion Criteria
  1. cardiopulmonary disease.
  2. severe hepatorenal dysfunction.
  3. history of upper respiratory tract infection 2 weeks before the operation.
  4. overweight [more than 20% of standard body weight].
  5. neuromuscular disease.
  6. anticipated difficult airway.
  7. hiatus hernia or gastroesophageal reflux disease.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
vCV groupvolume controlled ventilationPediatric patients in the PCV group(n=30) received pressure-controlled ventilation. The initial parameters will be as follows: the peak inspiratory pressure (PIP) will set to provide a tidal volume of 7 ml/kg , respiratory rate will be 16 breaths/min, inspiratory to expiratory ratio was 1:2 with an upper limit of PIP of 20 cm H2O.
PCV grouppressure controlled ventilationPediatric patients in the PCV group(n=30) received pressure-controlled ventilation. The initial parameters will be as follows: the peak inspiratory pressure (PIP) will set to provide a tidal volume of 7 ml/kg , respiratory rate will be 16 breaths/min, inspiratory to expiratory ratio was 1:2 with an upper limit of PIP of 20 cm H2O.
PCV-VG grouppressure controlled volume grantanteed ventilationPediatric patients in the PCV-VG group (n=30)will be conducted with pressure-controlled volume-guaranteed ventilation, target tidal volume will set at 7 mL/kg, with a respiratory rate of 16 breaths/min and a respiratory ratio of 1:2.
Primary Outcome Measures
NameTimeMethod
(PIP)within one hour

peak inspiratory pressure

Pplatwithin one hour

plateau airway pressure

(Cdyn)within one hour

pulmonary dynamic compliance

(RAWwithin one hour

airway resistance

VTwithin one hour

exhaled tidal volume

EtCO2within one hour

end-expiratory carbon dioxide

Vd/VTwithin one hour

physiologic dead space over tidal volume

Secondary Outcome Measures
NameTimeMethod
(MAP)within one hour

mean arterial pressure

(HR)within one hour

heart rate

postoperative respiratory adverse eventswithin 24 hour

cough, hoarseness, sore throat, hypoxemia, laryngospasm, bronchospasm.

Trial Locations

Locations (1)

Benisuef university hospital

🇪🇬

Benisuef, Egypt

© Copyright 2025. All Rights Reserved by MedPath